Executive Appointment

Tampa, FL and London – October 29, 2026 -- Akari Therapeutics (Nasdaq: AKTX) has appointed Vatnak Vat-Ho as Chief Business Officer, adding an executive who has held senior roles in oncology transactions totaling more than $25 billion in aggregate value.

Vat-Ho will run corporate strategy, partnering, licensing and investor engagement

Vat-Ho will lead corporate and business development at the oncology biotech, which is developing antibody drug conjugates (ADCs) built on a novel RNA splicing-disrupting payload called PH1. His remit covers corporate strategy, partnering and licensing, and investor engagement as the company advances its lead TROP2-targeted ADC, AKTX-101, toward the clinic.

He brings more than 20 years of experience across oncology business development, biopharmaceutical strategy, equity research and healthcare investing. His transaction record involves Pfizer, Exelixis, BioNTech, Merck KGaA, Roivant and Roche/Genentech.

NEW YORK – October 29, 2026 -- Sol, a vendor-neutral AI-enabled business and IT transformation firm, has appointed Dan Silberman, who spent twenty years at A+E Global Media, as Head of Marketing & Communications. He reports to Managing Partner Kaan Aslansan and is based in New York.

Silberman takes end-to-end ownership of Sol's brand and pipeline-linked marketing

Silberman's remit covers positioning and narrative, earned media, content and thought leadership, digital presence, internal communications and reputation management. Sol ties the work directly to pipeline and growth.

Aslansan framed the hire as a shift from delivery to visibility: the firm has built its business on delivery and is now investing in making sure the market knows it. He said Silberman will make sure the market sees "what our clients already do."

Denver – October 28, 2026 -- EverPeak Insurance has appointed Patrick K. Daley, CPCU, a underwriter with more than 30 years of experience in large, complex and hard-to-place risks, as Chief Underwriting Officer. He will lead underwriting strategy and quality standards across all EverPeak lines of business.

Daley's first mandate targets workers' compensation and BOP

Daley's first priority is a new value proposition for EverPeak's Workers' Compensation Middle Market business, which has long relied on deep data analysis, technology and service. He will also lead the relaunch of Attune's Business Owner's Policy (BOP) product. He will cross-sell BOP and other products to EverPeak's workers' compensation customers.

EverPeak President Kathy Kranz said his expertise in complex and hard-to-place risk is "exactly what we need" as the company expands its offerings.

Rossville, Md. – October 28, 2026 -- LifeLogics, a nonprofit technology company serving the organ and tissue donation and transplantation community, has appointed Ankit Mathur as Chief Executive Officer. Mathur, who has more than two decades of experience in technology, healthcare and organizational leadership, most recently served as Chief Technology Officer of United Network for Organ Sharing (UNOS).

Mathur's mandate centers on platform modernization and interoperability

Mathur will lead LifeLogics through what the company calls its next phase of growth and modernization. His priorities are strengthening partnerships with organ procurement organizations (OPOs), advancing the company's technology platforms, improving customer experience and expanding interoperability across the donation ecosystem.

DENVER – October 28, 2026 -- Onward Energy, an independent power producer with a 6.6 GW portfolio, has appointed Chief Financial Officer Patrick Welch as CEO and promoted Adam Heath to CFO, both effective October 29, 2026.

Welch moves from interim CEO to the permanent role and joins the board

Welch, CFO since 2023 and currently Interim President and CEO, will also join Onward's board of directors. He has more than 34 years of energy and power experience, including 18 years in CFO roles at Atlantic Power, JP Energy Partners and Jonah Energy.

Onward initially recruited him to build its finance function. He has since led the company through major financing transactions, built an enterprise risk management program and developed talent and organizational structures meant to support scale.

SAN FRANCISCO – October 28, 2026 -- Corgi Insurance, an AI-native, full-stack commercial insurance carrier, has appointed Josh LaRiccia as Head of Distribution, a hire who previously onboarded 15,000 users and 13,000 agencies onto a platform at his own firm.

LaRiccia built distribution at First Insurance & Risk Management over four years

LaRiccia co-founded First Insurance & Risk Management and spent four years building its distribution operations from scratch. He developed relationships with agents, wholesalers and industry partners that formed the firm's distribution network and market presence.

TORONTO – October 28, 2026 -- Tully Luxury Travel has appointed Steven Salm as Chief Executive Officer, and he has bought founder Mary Jean Tully's remaining shareholding, making him a co-owner of the business. Tully steps down as CEO after nearly four decades and stays on as Brand Ambassador.

Salm buys the founder's stake and joins Jacobs as co-owner

Salm now holds equity alongside Executive Chairman and majority shareholder Clive Jacobs. The source does not disclose the terms of the share purchase.

Jacobs made the appointment. He and Salm will jointly set long-term strategy, while Salm runs day-to-day operations and growth as CEO.

Salm moves up from COO after about one year at the firm

Salm joined Tully as Chief Operating Officer in 2025 and was named CEO in October 2026. Jacobs said Salm had "proven in a short time" that he is the leader the company needs for its next chapter.

Kirkland, Wash. – October 28, 2026 -- EIT Pharma has appointed Dr. Joseph Toerner, a 26-year veteran of the U.S. Food and Drug Administration (FDA), as Chief Medical Officer, effective immediately, while its lead hepatitis D candidate lonafarnib is under regulatory review.

Former FDA hepatology director takes clinical lead on two programs

Toerner will provide medical and clinical leadership across EIT Pharma's development programs. That includes supporting the ongoing regulatory review of lonafarnib, a late-stage, first-in-class oral therapy for chronic hepatitis D (CHD), and peginterferon lambda, a Phase 2 treatment for severe acute viral respiratory infections.

EIT Pharma describes lonafarnib as the only oral therapeutic candidate in late-stage clinical development for CHD. The drug has not been approved by the FDA or any other regulatory authority, and its safety and efficacy have not been established.

Plainfield – October 28, 2026 -- PairSoft has appointed Vijay Vidiyala, an enterprise software executive with more than 20 years of experience, as Chief Product & Technology Officer (CPTO) to lead its product and engineering teams in building AI-driven solutions for the office of the CFO.

Vidiyala brings Model N and SAP experience to PairSoft's product organization

Vidiyala most recently led product, engineering, and operations teams across the U.S., Europe, and India at Model N. There he helped shape the company's SaaS transition strategy. Before that, he spent a decade at SAP, leading product development and go-to-market activities for cloud solutions.

Innsbruck – October 28, 2026 -- Congress Messe Innsbruck (CMI) has appointed Igor Palka, a Messe Berlin division head, as its new managing director, effective March 1, 2027.

Palka brings more than 20 years of trade fair and congress experience to CMI

Palka was born in Munich in 1983 and has worked in the trade fair, congress and events industry both nationally and internationally. He was responsible for several industrial trade fairs and for an international subsidiary of Messe München. That role gave him experience in international markets, particularly in Asia.

Palka currently runs technology fairs and internationalization at Messe Berlin

At Messe Berlin he heads the division covering technology fairs, new business development and internationalization. He is a member of the company's management team and is responsible for developing new business fields and the company's international orientation.